Regulation of tissue ingrowth into proteolytically degradable hydrogels
Source abstract
Abstract
Regulation of the rate of cell ingrowth into and within a matrix is desirable for efficient tissue regeneration. Polyethylene glycol hydrogels crosslinked with matrix metalloproteinase (MMP) susceptible peptide sequences permit cell-controlled invasion. In this study, hydrogels of the same stiffness polymerised using different ratios of a readily degradable MMP peptide sequence (PAN-MMP) and a MMP peptide with a limited degradation capacity (MMP-9) were assessed both in vitro and in vivo for cellular invasion. The degree of invasion into the various hydrogels was found to be tightly linked to the relative proportion of each peptide both in vitro and in vivo. Furthermore a good correlation between in vitro and in vivo ingrowth was observed. These findings demonstrate a highly tunable model for regulating cellular invasion which is readily translatable to in vivo models. This finding may allow for further optimisation of aspects of regenerative scaffolds such as tissue invasion, growth factor release and cellular encapsulation. Statement of significance Degradable hydrogels are used in a wide range of tissue regeneration approaches. A particularly advantageous variant of these hydrogels is where due to peptide based crosslinking of the polymeric hydrogels, cell invasion rate is dependent on cellular enzymatic activity. This present study demonstrates a further refinement whereby both cellular and tissue invasion rates are finely regulated through the polymerisation of a hydrogel with varying combinations of enzymatically degradable peptides. Importantly this allows for invasion rates to be controlled without altering the biomechanical properties of the hydrogel such as stiffness. The latter can further influence cellular behaviour thus potentially interfering with the desired outcome.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Silk-based biomaterials and applications · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Assessment of tissue ingrowth rates in polyurethane scaffolds for tissue engineering10.1089/ten.2005.11.1212 ↗
2. Smart polymeric gels: redefining the limits of biomedical devices10.1016/j.progpolymsci.2007.05.018 ↗
3. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration10.1529/biophysj.104.050682 ↗
4. Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds as a cell delivery vehicle: characterization of PC12 cell response10.1002/btpr.1761 ↗
5. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics10.1073/pnas.0737381100 ↗
6. A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells10.1096/fj.10-165514 ↗
7. The dosage dependence of VEGF stimulation on scaffold neovascularisation10.1016/j.biomaterials.2008.05.007 ↗
8. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes10.1089/ten.2006.12.2093 ↗
9. Paracrine mechanisms in adult stem cell signaling and therapy10.1161/CIRCRESAHA.108.176826 ↗
10. Elucidating the role of matrix stiffness in 3D cell migration and remodeling10.1016/j.bpj.2010.11.082 ↗
11. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering10.1038/nbt1055 ↗
12. Mechanical properties of brain tissue in-vivo: experiment and computer simulation10.1016/S0021-9290(00)00120-2 ↗
13. Challenges and emerging technologies in the immunoisolation of cells and tissues10.1016/j.addr.2007.08.034 ↗
14. Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention10.1002/jbm.820280710 ↗
15. Cell-compatible hydrogels based on a multifunctional crosslinker with tunable stiffness for tissue engineering10.1039/c2jm34862d ↗
16. The effects of varying poly(ethylene glycol) hydrogel crosslinking density and the crosslinking mechanism on protein accumulation in three-dimensional hydrogels10.1016/j.actbio.2014.05.023 ↗
17. J.R. Tse, A.J. Engler, Preparation of hydrogel substrates with tunable mechanical properties, Current protocols in cell biology/editorial board, Juan S. Bonifacino et al., 2010, Chapter 10: Unit 10 6.10.1002/0471143030.cb1016s47 ↗
18. Matrix elasticity directs stem cell lineage specification10.1016/j.cell.2006.06.044 ↗
19. The effect of matrix stiffness on mesenchymal stem cell differentiation in a 3D thixotropic gel10.1016/j.biomaterials.2009.09.057 ↗
20. Cell specific ingrowth hydrogels10.1016/j.biomaterials.2013.05.057 ↗
21. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-210.1016/j.biomaterials.2010.06.061 ↗
22. Evaluation of MMP substrate concentration and specificity for neovascularization of hydrogel scaffolds10.1039/C4BM00088A ↗
23. Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition10.1021/bm025744e ↗
24. A. Takashima, Establishment of fibroblast cultures, Current protocols in cell biology/editorial board, Juan S. Bonifacino et al., 2001, Chapter 2: Unit 2 1.
25. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation10.1083/jcb.143.5.1341 ↗
26. Effect of well defined dodecahedral porosity on inflammation and angiogenesis10.1097/00002480-200209000-00004 ↗
27. Substrate hydrolysis by matrix metalloproteinase-910.1074/jbc.M100900200 ↗
28. Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes10.1016/j.biomaterials.2013.03.012 ↗
29. Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-A and platelet-derived growth factor-BB10.1089/ten.tea.2011.0192 ↗
30. Controlled proteolytic cleavage site presentation in biomimetic PEGDA hydrogels enhances neovascularization in vitro10.1089/ten.tea.2012.0173 ↗
31. Proteinase K from Tritirachium album limber10.1111/j.1432-1033.1974.tb03671.x ↗
32. Proteolytic enzymes for peptide production
33. Alterations in cultured myocardial fibroblast function following the development of left ventricular failure10.1016/j.yjmcc.2006.01.019 ↗
34. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease10.1186/1755-1536-5-15 ↗
35. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting10.1242/jcs.112.19.3249 ↗
36. Matrix metalloproteinase proteomics: substrates, targets, and therapy10.1016/j.ceb.2009.06.006 ↗
37. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics10.1016/j.bbamcr.2009.09.015 ↗
38. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)10.1080/10409230290771546 ↗
39. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size10.1161/01.STR.29.5.1020 ↗
40. Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 910.1189/jlb.1008588 ↗
41. Cutaneous wound healing10.1056/NEJM199909023411006 ↗
42. In vitro models for the blood–brain barrier10.1016/j.tiv.2004.06.011 ↗